Cotreatment with panobinostat and JAK2 inhibitor TG101209 attenuates JAK2V617F levels and signaling and exerts synergistic cytotoxic effects against human myeloproliferative neoplastic cells. (Q37460337)
Jump to navigation
Jump to search
scientific article published on 14 October 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cotreatment with panobinostat and JAK2 inhibitor TG101209 attenuates JAK2V617F levels and signaling and exerts synergistic cytotoxic effects against human myeloproliferative neoplastic cells. |
scientific article published on 14 October 2009 |
Statements
Cotreatment with panobinostat and JAK2 inhibitor TG101209 attenuates JAK2V617F levels and signaling and exerts synergistic cytotoxic effects against human myeloproliferative neoplastic cells (English)
Yongchao Wang
Warren Fiskus
Daniel G Chong
Kathleen M Buckley
Kavita Natarajan
Rekha Rao
Ramesh Balusu
Sanjay Koul
Jianguang Chen
Andrew Savoie
Celalettin Ustun
Anand P Jillella
Peter Atadja
Ross L Levine
Kapil N Bhalla
14 October 2009
1 reference
1 reference
1 reference
1 reference